Comprehensive Stock Analysis of Can-Fite Biopharma Ltd(NYSE:CANF): Pedevco Corp.(NYSE:PED)

0
9

Many analysts are providing their Estimated Earnings analysis for Can-Fite Biopharma Ltd and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

Some buy side analysts are also providing their Analysis on Can-Fite Biopharma Ltd, where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

Can-Fite Biopharma Ltd closed its last trading session at $1.29 with the gain of 0%. The Market Capitalization of the company stands at 51.22 Million. The Company has 52-week high of $2.75 and 52-week low of $1.12. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -6.23% where SMA50 and SMA200 are -1.86% and -4.04% respectively. The Company Touched its 52-Week High on 01/25/18 and 52-Week Low on 07/02/18.

The Relative Volume of the company is 0.62 and Average Volume (3 months) is 99.94 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of 0%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Can-Fite Biopharma Ltd currently shows a Weekly Performance of -8.51%, where Monthly Performance is 0.78%, Quarterly performance is 4.03%, 6 Months performance is 0.78% and yearly performance percentage is -9.15%. Year to Date performance value (YTD perf) value is -12.84%. The Stock currently has a Weekly Volatility of 7.60% and Monthly Volatility of 6.06%.

Many analysts are providing their Estimated Earnings analysis for Pedevco Corp. and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

Pedevco Corp. closed its last trading session at $1.46 with the loss of -0.68%. The Market Capitalization of the company stands at 23.68 Million. The Company has 52-week high of $4.44 and 52-week low of $0.26. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -9.08% where SMA50 and SMA200 are -20.79% and 14.48% respectively. The Company Touched its 52-Week High on 06/28/18 and 52-Week Low on 02/08/18.

The Relative Volume of the company is 0.53 and Average Volume (3 months) is 119.72 million. The company’s P/E (price to earnings) ratio is 9.06 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of 86.8%. The Return on Equity (ROE) value stands at -475.3%. While it’s Return on Investment (ROI) value is -78.6%.

While looking at the Stock’s Performance, Pedevco Corp. currently shows a Weekly Performance of -5.84%, where Monthly Performance is -9.94%, Quarterly performance is -40.08%, 6 Months performance is 367.74% and yearly performance percentage is 364%. Year to Date performance value (YTD perf) value is 353.27%. The Stock currently has a Weekly Volatility of 6.17% and Monthly Volatility of 11.48%.

SHARE